Disease activity has a significant impact in progression of primary progressive multiple sclerosis

被引：0
作者：
Marrodan, M. [1 ]
Bensi, C. [1 ]
Pappolla, A. [2 ]
Rojas, J. I. [2 ]
Patrucco, L. [2 ]
Farez, M. F. [1 ,3 ]
Cristiano, E. [2 ]
Correale, J. [1 ]
机构：
[1] FLENI, Neurol, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Neurol, Buenos Aires, DF, Argentina
[3] FLENI, Ctr Biostat Epidemiol & Publ Hlth CEBES, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P752
引用
收藏
页码：382 / 382
页数：1
相关论文
共 50 条
  • [31] Primary progressive multiple sclerosis
    Thompson, AJ
    Polman, CH
    Miller, DH
    McDonald, WI
    Brochet, B
    Filippi, M
    Montalban, X
    DeSa, J
    BRAIN, 1997, 120 : 1085 - 1096
  • [32] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, Xavier
    Wolinsky, Jerry
    Kappos, Ludwig
    Hauser, Stephen L.
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP10 - NP10
  • [33] Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Wolinsky, Jerry S.
    Montalban, Xavier
    Hauser, Stephen L.
    Giovannoni, Gavin
    Vermersch, Patrick
    Bernasconi, Corrado
    Deol-Bhullar, Gurpreet
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Kappos, Ludwig
    ANNALS OF NEUROLOGY, 2018, 84 (04) : 527 - 536
  • [34] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in Patients with Primary Progressive Multiple Sclerosis in the ORATORIO Trial
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bemasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Douglas
    NEUROLOGY, 2017, 88
  • [35] EVALUATION OF NO EVIDENCE OF PROGRESSION OR ACTIVE DISEASE (NEPAD) IN PATIENTS WITH PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS IN THE ORATORIO TRIAL
    Wolinsky, Jerry
    Montalban, Xavier
    Kappos, Ludwig
    Hauser, Stephen
    Giovannoni, Gavin
    de Seze, Jerome
    Bar-Or, Amit
    Masterman, Donna
    Bernasconi, Corrado
    Wei, Wei
    Garren, Hideki
    Chin, Peter
    Belachew, Shibeshih
    Arnold, Doug L.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (05)
  • [36] Evaluation of No Evidence of Progression or Active Disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
    Montalban, X.
    Wolinsky, J.
    Kappos, L.
    Hauser, S. L.
    Giovannoni, G.
    de Seze, J.
    Bar-or, A.
    Masterman, D.
    Bernasconi, C.
    Wei, W.
    Garren, H.
    Chin, P.
    Belachew, S.
    Arnold, D. L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 576 - 576
  • [37] Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
    Beynon, Vanessa
    George, Ilena C.
    Elliott, Colm
    Arnold, Douglas L.
    Ke, Jun
    Chen, Huaihou
    Zhu, Li
    Ke, Chunlei
    Giovannoni, Gavin
    Scaramozza, Matthew
    Campbell, Nolan
    Bradley, Daniel P.
    Franchimont, Nathalie
    Gafson, Arie
    Belachew, Shibeshih
    BMJ NEUROLOGY OPEN, 2022, 4 (01)
  • [38] The impact of smoking cessation on multiple sclerosis disease progression
    Rodgers, W. J.
    Friede, T.
    Vonberg, F. W.
    Constantinescu, C. S.
    Coles, A.
    Chataway, J.
    Emsley, H.
    Ford, H.
    Fisniku, L.
    Galea, I.
    Harrower, T.
    Hobart, J.
    Huseyin, H.
    Kipps, C.
    Marta, M.
    McDonnell, G.
    McLean, B.
    Pearson, O. R.
    Rog, D.
    Schmierer, K.
    Sharrack, B.
    Straukiene, A.
    Wilson, H.
    Middleton, R.
    Ford, D. V.
    Nicholas, R.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 41 - 42
  • [39] Clinical impact of gender and age at onset on disease trajectory in primary progressive multiple sclerosis patients
    Camerlingo, Sebastian
    Rubinstein, Fernando
    Ysrraelit, Maria Celia
    Correale, Jorge
    Contentti, Edgar Carnero
    Rojas, Juan, I
    Patrucco, Liliana
    Leguizamon, Felisa del Valle
    Tkachuk, Veronica
    Liguori, Nora Fernandez
    Cristiano, Edgardo
    Mainella, Carolina
    Zanga, Gisela
    Carra, Adriana
    Marrodan, Mariano
    Martinez, Alejandra Diana
    Silva, Berenice Anabel
    Alonso, Ricardo
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 336 - 344
  • [40] The impact of smoking cessation on multiple sclerosis disease progression
    Rodgers, Jeff
    Friede, Tim
    Vonberg, Frederick W.
    Constantinescu, Cris S.
    Coles, Alasdair
    Chataway, Jeremy
    Duddy, Martin
    Emsley, Hedley
    Ford, Helen
    Fisniku, Lennora
    Galea, Ian
    Harrower, Timothy
    Hobart, Jeremy
    Huseyin, Huseyin
    Kipps, Christopher M.
    Marta, Monica
    McDonnell, Gavin, V
    McLean, Brendan
    Pearson, Owen R.
    Rog, David
    Schmierer, Klaus
    Sharrack, Basil
    Straukiene, Agne
    Wilson, Heather C.
    Ford, David, V
    Middleton, Rod M.
    Nicholas, Richard
    BRAIN, 2022, 145 (04) : 1368 - 1378
12345